Early Amiodarone in Shockable Cardiac Arrest

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 585 participants.

Also called NCT06680869

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 585 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06680869
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06680869. Randomized; no masking; primary purpose treatment. Start 2025-01-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Amiodarone in Shockable Cardiac Arrest
Acronym
Early-Amio
Intervention (Drug)
Amiodarone Hydrochloride Injection
Intervention (Other)
Usual Care Protocol
Lead sponsor
Oregon Health and Science University (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct06680869
Content hash
0d6eb12a3e091f6e4ad727648aa14c6af392c9cdb8c8e446059bc1b687a0f27f